Abstract | PURPOSE: MATERIALS AND METHODS: The human colon cancer cell line HT29, transfected with luciferase cDNA for in vivo bioluminescence monitoring, was injected intrasplenically into CB17.SCID mice. Mice were monitored weekly by bioluminescence and after 2 and 4.5 weeks by HRU and CEUS. Contrast media (untargeted BR1, targeted BR55) was applied and digital cine loops from the arterial phase (15 - 45 sec), portal venous phase (50 - 120 s) and late phases (3 - 5 min, 1hour) of the whole liver were analyzed. Data were correlated with postmortem histopathology. RESULTS: Without contrast enhancement, lesions > 4 mm were reliably detected. After use of untargeted CEUS, lesions > 2 mm were reliably detected and enhanced rim vascularization and late-phase wash-out was shown. With BR55, lesions > 0.8 mm were reliably detected with excellent documentation of vascularization. A persistent contrast enhancement was seen > 30 min after injection. Contrast-enhancement patterns with BR55 significantly correlated with CD31 (R2 = 0.74) and VEGFR2-immunohistochemistry (R2 = 0.66). CONCLUSION: Detection of metastases by HRU and CEUS was earlier and more accurate than monitoring via bioluminescence. In vivo monitoring of hepatic micrometastases can thus be performed without prior modification of cancer cells using standard technology.
|
Authors | C Hackl, D Schacherer, M Anders, L M Wiedemann, A Mohr, H J Schlitt, C Stroszczynski, F Tranquart, E M Jung |
Journal | Ultraschall in der Medizin (Stuttgart, Germany : 1980)
(Ultraschall Med)
Vol. 37
Issue 3
Pg. 290-6
(Jun 2016)
ISSN: 1438-8782 [Electronic] Germany |
Vernacular Title | Verbesserte Detektion präklinischer kolorektaler Lebermetastasen durch hochauflösenden Ultraschall und Molekulares Imaging durch das gezielt bindende Kontrastmittel BR55. |
PMID | 27112624
(Publication Type: Comparative Study, Journal Article)
|
Copyright | © Georg Thieme Verlag KG Stuttgart · New York. |
Chemical References |
- Contrast Media
- Lipopeptides
- KDR protein, human
- Vascular Endothelial Growth Factor Receptor-2
|
Topics |
- Animals
- Colonic Neoplasms
(diagnostic imaging)
- Contrast Media
- Female
- HT29 Cells
- Humans
- Image Enhancement
- Lipopeptides
(administration & dosage)
- Liver
(diagnostic imaging)
- Liver Neoplasms
(diagnostic imaging, secondary)
- Luminescent Measurements
- Mice
- Mice, Inbred Strains
- Microbubbles
- Molecular Imaging
- Neoplasm Transplantation
- Ultrasonography
- Vascular Endothelial Growth Factor Receptor-2
|